Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-25-007748
Filing Date
2025-05-14
Accepted
2025-05-14 16:10:12
Documents
63
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q fencf-20250331x10q.htm   iXBRL 10-Q 1202384
2 EX-31.1 fencf-20250331xex31d1.htm EX-31.1 14629
3 EX-31.2 fencf-20250331xex31d2.htm EX-31.2 19051
4 EX-32.1 fencf-20250331xex32d1.htm EX-32.1 10616
5 EX-99.1 fencf-20250331xex99d1.htm EX-99.1 184774
6 GRAPHIC fencf-20250331xex99d1001.jpg GRAPHIC 3171
  Complete submission text file 0001558370-25-007748.txt   6159019

Data Files

Seq Description Document Type Size
7 EX-101.SCH fencf-20250331.xsd EX-101.SCH 50399
8 EX-101.CAL fencf-20250331_cal.xml EX-101.CAL 40643
9 EX-101.DEF fencf-20250331_def.xml EX-101.DEF 198155
10 EX-101.LAB fencf-20250331_lab.xml EX-101.LAB 338781
11 EX-101.PRE fencf-20250331_pre.xml EX-101.PRE 307495
66 EXTRACTED XBRL INSTANCE DOCUMENT fencf-20250331x10q_htm.xml XML 937102
Mailing Address PO BOX 13628 68 TW ALEXANDER DRIVE RESEARCH TRIANGLE PARK NC 27709
Business Address PO BOX 13628 68 TW ALEXANDER DRIVE RESEARCH TRIANGLE PARK NC 27709 (919) 636-4530
FENNEC PHARMACEUTICALS INC. (Filer) CIK: 0001211583 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32295 | Film No.: 25945540
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)